Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lowther

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMJ Open|July 31, 2021
Life under COVID-19 for LGBT+ people in the UK: systematic review of UK research on the impact of COVID-19 on sexual and gender minority populationsVictoria J McGowan, Hayley J Lowther, Catherine Meads
British Journal of Neuroscience Nursing|May 29, 2024
Effectiveness of quality improvement collaboratives in improving clinical processes and patient outcomes in stroke careO Hamer, H J Lowther, H Harrison, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinemE Di Modugno, R Broggio, I Erbetti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2020
Quantifying the dose accumulation uncertainty after deformable image registration in head-and-neck radiotherapyNicholas J Lowther, Steven H Marsh, Robert J W Louwe
Physics and Imaging in Radiation Oncology|January 18, 2021
Dose accumulation to assess the validity of treatment plans with reduced margins in radiotherapy of head and neck cancerNicholas J Lowther, Steven H Marsh, Robert J W Louwe
Journal of Virology|February 27, 2001
Downregulation of IRF-3 levels by ribozyme modulates the profile of IFNA subtypes expressed in infected human cellsW S Yeow, W C Au, W J Lowther, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2003
In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis modelD Andes, K Marchillo, J Lowther, et al.
DNA and Cell Biology|September 24, 1999
Cloning and functional analysis of the human IRF-3 promoterW J Lowther, P A Moore, K C Carter, et al.
Journal of Applied Microbiology|November 19, 2011
The development of LENTICULES™ as reference materials for norovirusesR Hartnell, J Lowther, J Avant, et al.
BMC Health Services Research|September 29, 2023
Understanding inequalities in access to adult mental health services in the UK: a systematic mapping reviewHayley J Lowther-Payne, Anastasia Ushakova, Adelaide Beckwith, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMJ Open|July 31, 2021
Life under COVID-19 for LGBT+ people in the UK: systematic review of UK research on the impact of COVID-19 on sexual and gender minority populationsVictoria J McGowan, Hayley J Lowther, Catherine Meads
British Journal of Neuroscience Nursing|May 29, 2024
Effectiveness of quality improvement collaboratives in improving clinical processes and patient outcomes in stroke careO Hamer, H J Lowther, H Harrison, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinemE Di Modugno, R Broggio, I Erbetti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2020
Quantifying the dose accumulation uncertainty after deformable image registration in head-and-neck radiotherapyNicholas J Lowther, Steven H Marsh, Robert J W Louwe
Physics and Imaging in Radiation Oncology|January 18, 2021
Dose accumulation to assess the validity of treatment plans with reduced margins in radiotherapy of head and neck cancerNicholas J Lowther, Steven H Marsh, Robert J W Louwe
Journal of Virology|February 27, 2001
Downregulation of IRF-3 levels by ribozyme modulates the profile of IFNA subtypes expressed in infected human cellsW S Yeow, W C Au, W J Lowther, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2003
In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis modelD Andes, K Marchillo, J Lowther, et al.
DNA and Cell Biology|September 24, 1999
Cloning and functional analysis of the human IRF-3 promoterW J Lowther, P A Moore, K C Carter, et al.
Journal of Applied Microbiology|November 19, 2011
The development of LENTICULES™ as reference materials for norovirusesR Hartnell, J Lowther, J Avant, et al.
BMC Health Services Research|September 29, 2023
Understanding inequalities in access to adult mental health services in the UK: a systematic mapping reviewHayley J Lowther-Payne, Anastasia Ushakova, Adelaide Beckwith, et al.
Pageof 2